Aerpio Pharmaceuticals, Inc.
ARPO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $7,145 | $22,982 |
| % Growth | – | -100% | -68.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $142 |
| Gross Profit | $0 | $0 | $0 | $22,840 |
| % Margin | – | – | 0% | 99.4% |
| R&D Expenses | $14,345 | $48,809 | $8,788 | $25,189 |
| G&A Expenses | $0 | $0 | $0 | $8,471 |
| SG&A Expenses | $5,201 | $5,940 | $12,815 | $28,278 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $19,807 |
| Other Operating Expenses | $0 | $0 | $760 | $0 |
| Operating Expenses | $19,546 | $54,749 | $22,363 | $53,467 |
| Operating Income | -$19,546 | -$54,749 | -$15,218 | -$36,147 |
| % Margin | – | – | -213% | -157.3% |
| Other Income/Exp. Net | $1,800 | $2,134 | $88,234 | $0 |
| Pre-Tax Income | -$17,746 | -$52,615 | $73,016 | -$14,493 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$17,746 | -$52,615 | $73,016 | -$14,493 |
| % Margin | – | – | 1,021.9% | -63.1% |
| EPS | -0.26 | -0.76 | 1.84 | -1.04 |
| % Growth | 65.8% | -141.3% | 276.9% | – |
| EPS Diluted | -0.26 | -0.76 | 2.7 | -1.04 |
| Weighted Avg Shares Out | 69,205 | 69,083 | 27,030 | 27,030 |
| Weighted Avg Shares Out Dil | 69,205 | 69,083 | 27,030 | 27,030 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,850 | $1,979 | $791 | $2,732 |
| Interest Expense | $0 | $0 | $0 | -$154 |
| Depreciation & Amortization | $0 | $0 | $0 | -$679 |
| EBITDA | -$17,746 | -$54,749 | -$15,218 | -$36,826 |
| % Margin | – | – | -213% | -160.2% |